ALX Oncology Newsroom

LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating

Futu NewsNov 11 20:34

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Maintains Target Price $3

Futu NewsNov 8 23:31

Stifel Nicolaus Sticks to Its Hold Rating for ALX Oncology Holdings (ALXO)

TipRanksNov 8 22:41

Positive Outlook for ALX Oncology: Buy Rating Backed by Promising Clinical Data and Strong Financials

TipRanksNov 8 19:37

ALX Oncology Holdings Analyst Ratings

BenzingaAug 16 22:30

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target

BenzingaAug 13 19:20

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25

Futu NewsAug 13 18:31

Maintaining Buy Rating on ALX Oncology: Promising Clinical Data and Anticipated Progress of Evorpacept

TipRanksAug 13 18:26

ALX Oncology Holdings Analyst Ratings

BenzingaAug 12 20:37

ALX Oncology Holdings Analyst Ratings

BenzingaAug 9 20:25

ALX Oncology Price Target Cut to $5.00/Share From $14.00 by Stifel

Dow JonesAug 1 22:32

ALX Oncology Holdings Analyst Ratings

BenzingaAug 1 21:03

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target

BenzingaAug 1 21:03

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Cuts Target Price to $5

Futu NewsAug 1 20:31

Stifel Nicolaus Remains a Hold on ALX Oncology Holdings (ALXO)

TipRanksAug 1 20:15

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25

Futu NewsAug 1 18:31

Promising Future for ALX Oncology's Evorpacept: A Buy Rating Justified by Clinical Trials and FDA Prospects

TipRanksAug 1 18:24

Evaluating ALX Oncology's Evorpacept: A Cautious Hold Amid Uncertain Long-Term Outcomes

TipRanksAug 1 10:38

ALX Oncology Holdings Analyst Ratings

BenzingaJun 10 19:00

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $25 Price Target

BenzingaJun 10 19:00